Corrigendum to: Mitochondrial genome inheritance and replacement in the human germline (The EMBO Journal, (2017), 36, 15, (2177-2181), 10.15252/embj.201797606)

Don P. Wolf, Tomonari Hayama, Shoukhrat Mitalipov

    Research output: Contribution to journalComment/debate

    5 Scopus citations

    Abstract

    The conflict of interest section contains information that is incorrect. The correct conflict of interest statement is as follows: Oregon Health & Science University has the patent entitled “Method for mitochondrial DNA replacement in oocytes”. SM is an inventor of the patent. SM is also a founder and CEO of Mitogenome Therapeutics, Inc. DPW and TH declare that they have no conflict of interest.

    Original languageEnglish (US)
    Pages (from-to)2659
    Number of pages1
    JournalEMBO Journal
    Volume36
    Issue number17
    DOIs
    StatePublished - Sep 1 2017

    ASJC Scopus subject areas

    • Neuroscience(all)
    • Molecular Biology
    • Immunology and Microbiology(all)
    • Biochemistry, Genetics and Molecular Biology(all)

    Fingerprint Dive into the research topics of 'Corrigendum to: Mitochondrial genome inheritance and replacement in the human germline (The EMBO Journal, (2017), 36, 15, (2177-2181), 10.15252/embj.201797606)'. Together they form a unique fingerprint.

  • Cite this